
The French pharmaceutical company Sanofi has upgraded its 2021 financial guidance for earnings per share (business EPS), it reports in a press release on Thursday morning.
Sanofi is now expecting growth of around 14 percent for its business EPS at current exchange rates (CER). The French firm also adjusted its business EPS guidance upward in connection with the second quarterly report of the year. Back then, it reported a new EPS guidance of 12 percent, compared to its previous full-year growth rate of a high single-digit figure.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app